Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity. (Q34804920)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204664%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204664%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204664%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

C Zanna

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204664%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204664%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204664%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204664%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204664%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

1832-1837

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204664%20AND%20SRC:MED&resulttype=core&format=json

Chemotherapy-induced peripheral neuropathy

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Paclitaxel delivered as a 3-hr infusion with cisplatin in patients with gynecologic cancers: unexpected incidence of neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

The ACTH-(4-9) analog, ORG 2766, prevents taxol-induced neuropathy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Protection against cisplatin induced neurotoxicity by ORG 2766: histological and electrophysiological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

A randomized, multicenter, double-blind, placebo-controlled, dose-finding study of ORG 2766 in the prevention or delay of cisplatin-induced neuropathies in women with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Protective effects of glutathione on cisplatin neurotoxicity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

The role of glutathione in combination with cisplatin in the treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

The experimental neuroprotectant leukaemia inhibitory factor (LIF) does not compromise antitumour activity of paclitaxel, cisplatin and carboplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

AM424: history of a novel drug candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Clinical trials in ALS: an overview.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

The use of insulin-like growth factor I in the prevention of vincristine neuropathy in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Neurotrophin‐3 reverses experimental cisplatin‐induced peripheral sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Partial prevention of cisplatin-induced neuropathy by electroporation-mediated nonviral gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Image analysis of neuritic regeneration by adult rat dorsal root ganglion neurons in culture: quantification of the neurotoxicity of anticancer agents and of its prevention by nerve growth factor or basic fibroblast growth factor but not brain-deriv

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by cisplatin: behavioral, structural and biochemical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Nerve growth factor prevents experimental cisplatin neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Effect of Recombinant Human Nerve Growth Factor on Cisplatin Neurotoxicity in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Nerve growth factor prevents toxic neuropathy in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Oral administration of propentofylline, a stimulator of nerve growth factor (NGF) synthesis, recovers cholinergic neuronal dysfunction induced by the infusion of anti-NGF antibody into the rat septum.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

1 reference

7 January 2021

Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Effects of ALCAR on the fast axoplasmic transport in cultured sensory neurons of streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Acetyl-L-carnitine treatment increases choline acetyltransferase activity and NGF levels in the CNS of adult rats following total fimbria-fornix transection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Effects of acetyl-L-carnitine treatment and stress exposure on the nerve growth factor receptor (p75NGFR) mRNA level in the central nervous system of aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

Is lithium able to reverse neurological damage induced by vinca alkaloids? (Short communication).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900229-0

7 January 2021

10.1016/S0959-8049(02)00229-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12204664%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference